Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (41-50 of 204) with videos related to

Pageof 21
Sort By:
Clinical and Experimental Rheumatology|June 8, 2019
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Orso Maria Lucherini, Antonio Vitale, Laura Obici, et al.
Clinical and Experimental Rheumatology|May 10, 2018
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseasesOrso Maria Lucherini, Donato Rigante, Jurgen Sota, et al.
The Journal of Urology|May 18, 2007
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosisTiziano Scalvini, Paola Rossana Martini, Laura Obici, et al.
Muscle & Nerve|June 9, 2016
Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathyHartmut H-J Schmidt, Fabio Barroso, Alejandra González-Duarte, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 9, 2018
Progressive axonal polyneuropathy in a mitochondrial disorder: an uncommon association with familial amyloid neuropathyMarco Luigetti, Guido Primiano, Giulia Bisogni, et al.
Annals of Medicine|April 26, 2007
The workings of the amyloid diseasesVittorio Bellotti, Mario Nuvolone, Sofia Giorgetti, et al.
Haematologica|November 12, 2013
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approachGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Ageing Research Reviews|June 11, 2021
Age-related amyloidosis outside the brain: A state-of-the-art reviewMasayoshi Tasaki, Francesca Lavatelli, Laura Obici, et al.
Blood|December 2, 2004
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, et al.
Journal of the Peripheral Nervous System : JPNS|December 15, 2015
"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathyIsabel Conceição, Alejandra González-Duarte, Laura Obici, et al.
Pageof 21

Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
Clinical and Experimental Rheumatology|June 8, 2019
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Orso Maria Lucherini, Antonio Vitale, Laura Obici, et al.
Clinical and Experimental Rheumatology|May 10, 2018
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseasesOrso Maria Lucherini, Donato Rigante, Jurgen Sota, et al.
The Journal of Urology|May 18, 2007
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosisTiziano Scalvini, Paola Rossana Martini, Laura Obici, et al.
Muscle & Nerve|June 9, 2016
Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathyHartmut H-J Schmidt, Fabio Barroso, Alejandra González-Duarte, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 9, 2018
Progressive axonal polyneuropathy in a mitochondrial disorder: an uncommon association with familial amyloid neuropathyMarco Luigetti, Guido Primiano, Giulia Bisogni, et al.
Annals of Medicine|April 26, 2007
The workings of the amyloid diseasesVittorio Bellotti, Mario Nuvolone, Sofia Giorgetti, et al.
Haematologica|November 12, 2013
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approachGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Ageing Research Reviews|June 11, 2021
Age-related amyloidosis outside the brain: A state-of-the-art reviewMasayoshi Tasaki, Francesca Lavatelli, Laura Obici, et al.
Blood|December 2, 2004
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, et al.
Journal of the Peripheral Nervous System : JPNS|December 15, 2015
"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathyIsabel Conceição, Alejandra González-Duarte, Laura Obici, et al.
Pageof 21